Stephane Vignot

Reims, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

Safety of concurrent T-DM1 and radiation therapy in HER2-positive breast cancer with residual disease after neoadjuvant chemotherapy.

Safety of concurrent T-DM1 and radiation therapy in HER2-positive breast cancer with residual disease after neoadjuvant chemotherapy.

Journal: International journal of radiation biology

Published: June 04, 2026

Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France.

Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: May 05, 2026

Use, survival, and adverse events of dostarlimab monotherapy in advanced or recurrent endometrial cancer: a nationwide cohort study in France.

Use, survival, and adverse events of dostarlimab monotherapy in advanced or recurrent endometrial cancer: a nationwide cohort study in France.

Journal: The oncologist

Published: April 24, 2026

Overall survival according to COVID-19 mRNA vaccination co-exposure in patients treated with PD-(L)1 inhibitors: a French real-world cohort study.

Overall survival according to COVID-19 mRNA vaccination co-exposure in patients treated with PD-(L)1 inhibitors: a French real-world cohort study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 03, 2026

Age and sex disparities in drug shortage impacts: a 10-year nationwide study in France.

Age and sex disparities in drug shortage impacts: a 10-year nationwide study in France.

Journal: European journal of public health

Published: March 28, 2026

Do chemotherapies still have a place in the era of precision medicine?

Do chemotherapies still have a place in the era of precision medicine?

Journal: Bulletin du cancer

Published: March 02, 2026

Decoding and guidelines

Decoding and guidelines

Journal: Bulletin du cancer

Published: February 13, 2026

Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent dMMR Endometrial Cancer: A Nationwide Cohort Study in France.

Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent dMMR Endometrial Cancer: A Nationwide Cohort Study in France.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: February 06, 2026

The promise of a new world

The promise of a new world

Journal: Bulletin du cancer

Published: January 04, 2026

Improving CTVboost delineation after preoperative systemic therapy in breast cancer using deformable PET/CT registration.

Improving CTVboost delineation after preoperative systemic therapy in breast cancer using deformable PET/CT registration.

Journal: Breast (Edinburgh, Scotland)

Published: December 08, 2025

Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort.

Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort.

Journal: Breast cancer research : BCR

Published: November 28, 2025

A 2025 inventory in oncology news

A 2025 inventory in oncology news

Journal: Bulletin du cancer

Published: November 27, 2025

Showing 1-12 of 115

Last Updated: 09/26/2026